Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 2
1993 3
1994 1
1996 2
1999 4
2001 1
2002 1
2005 1
2007 2
2010 2
2011 1
2013 1
2018 1
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
TE1PA as Innovating Chelator for 64Cu Immuno-TEP Imaging: A Comparative in Vivo Study with DOTA/NOTA by Conjugation on 9E7.4 mAb in a Syngeneic Multiple Myeloma Model.
Navarro AS, Le Bihan T, Le Saëc P, Bris NL, Bailly C, Saï-Maurel C, Bourgeois M, Chérel M, Tripier R, Faivre-Chauvet A. Navarro AS, et al. Among authors: sai maurel c. Bioconjug Chem. 2019 Sep 18;30(9):2393-2403. doi: 10.1021/acs.bioconjchem.9b00510. Epub 2019 Aug 22. Bioconjug Chem. 2019. PMID: 31386357
Sensitivity of pretargeted immunoPET using 68Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with 18FDG PET-CT.
Foubert F, Gouard S, Saï-Maurel C, Chérel M, Faivre-Chauvet A, Goldenberg DM, Barbet J, Bailly C, Bodet-Milin C, Carlier T, Kraeber-Bodéré F, Touchefeu Y, Frampas E. Foubert F, et al. Among authors: sai maurel c. Oncotarget. 2018 Jun 8;9(44):27502-27513. doi: 10.18632/oncotarget.25514. eCollection 2018 Jun 8. Oncotarget. 2018. PMID: 29938001 Free PMC article.
Doubly radiolabeled liposomes for pretargeted radioimmunotherapy.
Mougin-Degraef M, Bourdeau C, Jestin E, Saï-Maurel C, Bourgeois M, Saëc PR, Thédrez P, Gestin JF, Barbet J, Faivre-Chauvet A. Mougin-Degraef M, et al. Among authors: sai maurel c. Int J Pharm. 2007 Nov 1;344(1-2):110-7. doi: 10.1016/j.ijpharm.2007.05.024. Epub 2007 May 18. Int J Pharm. 2007. PMID: 17592745
Comparative toxicity and efficacy of combined radioimmunotherapy and antiangiogenic therapy in carcinoembryonic antigen-expressing medullary thyroid cancer xenograft.
Kraeber-Bodéré F, Bodet-Milin C, Niaudet C, Saï-Maurel C, Moreau A, Faivre-Chauvet A, Thomare P, Deleris G, Estieu-Gionnet K, Bikfalvi A, Barbet J, Paris F. Kraeber-Bodéré F, et al. Among authors: sai maurel c. J Nucl Med. 2010 Apr;51(4):624-31. doi: 10.2967/jnumed.109.070714. J Nucl Med. 2010. PMID: 20351352 Free article.
Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors.
Rousseau C, Ruellan AL, Bernardeau K, Kraeber-Bodéré F, Gouard S, Loussouarn D, Saï-Maurel C, Faivre-Chauvet A, Wijdenes J, Barbet J, Gaschet J, Chérel M, Davodeau F. Rousseau C, et al. Among authors: sai maurel c. EJNMMI Res. 2011 Sep 1;1(1):20. doi: 10.1186/2191-219X-1-20. EJNMMI Res. 2011. PMID: 22214534 Free PMC article.
24 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page